Total Payments
$1,221
2024 Payments
$225.13
Companies
20
Transactions
73
Medicare Patients
22,117
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$1,100 (90.1%)
Education$121.43 (9.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,100 | 65 | 90.1% |
| Education | $121.43 | 8 | 9.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $263.54 | 17 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $185.74 | 12 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $155.38 | 8 | $0 (2024) |
| Amgen Inc. | $125.26 | 6 | $0 (2022) |
| Relypsa, Inc. | $74.01 | 5 | $0 (2020) |
| Genentech USA, Inc. | $71.24 | 5 | $0 (2019) |
| Mallinckrodt Enterprises LLC | $55.63 | 3 | $0 (2019) |
| Shire North American Group Inc | $45.43 | 3 | $0 (2018) |
| Daiichi Sankyo Inc. | $31.34 | 2 | $0 (2022) |
| CALLIDITAS THERAPEUTICS US INC. | $28.41 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $225.13 | 11 | AstraZeneca Pharmaceuticals LP ($55.59) |
| 2023 | $13.22 | 1 | AstraZeneca Pharmaceuticals LP ($13.22) |
| 2022 | $313.49 | 17 | Aurinia Pharma U.S., Inc. ($138.47) |
| 2021 | $90.71 | 5 | AstraZeneca Pharmaceuticals LP ($69.87) |
| 2020 | $76.53 | 5 | Takeda Pharmaceuticals U.S.A., Inc. ($17.03) |
| 2019 | $245.34 | 18 | Otsuka America Pharmaceutical, Inc. ($119.11) |
| 2018 | $79.40 | 5 | Amgen Inc. ($21.55) |
| 2017 | $177.47 | 11 | Mallinckrodt LLC ($42.45) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/03/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: NEPHROLOGY | ||||||
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 07/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: DIABETES | ||||||
| 07/22/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: Nephrology | ||||||
| 05/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/01/2024 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 04/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/05/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: Genetic Disease | ||||||
| 03/13/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/28/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/25/2022 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: NEPHROLOGY | ||||||
| 08/23/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/29/2022 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Nephrology | ||||||
| 05/11/2022 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Nephrology | ||||||
| 05/10/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/03/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: IMMUNOLOGY | ||||||
| 04/08/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $53.32 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 03/24/2022 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Nephrology | ||||||
| 03/11/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.45 | General |
| 03/09/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/03/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: LUPUS NEPHRITIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 4,732 | 8,615 | $2.3M | $322,445 |
| 2022 | 33 | 4,465 | 7,446 | $1.1M | $315,362 |
| 2021 | 41 | 6,220 | 9,918 | $1.2M | $355,203 |
| 2020 | 39 | 6,700 | 14,205 | $1.4M | $370,787 |
Total Patients
22,117
Total Services
40,184
Medicare Billing
$1.4M
Procedure Codes
149
All Medicare Procedures & Services
149 procedure records from CMS Medicare Utilization — Page 6 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 251 | 251 | $12,786 | $4,326 | 33.8% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2020 | 502 | 728 | $15,397 | $3,724 | 24.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 33 | 33 | $9,993 | $3,267 | 32.7% |
| 84156 | Total protein level, urine | Office | 2020 | 519 | 771 | $11,565 | $2,792 | 24.1% |
| 84100 | Phosphate level | Office | 2020 | 409 | 594 | $10,621 | $2,781 | 26.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 442 | 696 | $6,264 | $2,065 | 33.0% |
| 80069 | Kidney function blood test panel | Office | 2020 | 195 | 228 | $6,430 | $1,959 | 30.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 33 | 33 | $2,977 | $1,716 | 57.7% |
| 84550 | Uric acid level, blood | Office | 2020 | 277 | 378 | $6,985 | $1,683 | 24.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 15 | 15 | $6,149 | $1,563 | 25.4% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 48 | 49 | $2,367 | $1,433 | 60.6% |
| 81003 | Automated urinalysis test | Office | 2020 | 375 | 534 | $4,902 | $1,183 | 24.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2020 | 19 | 21 | $3,967 | $1,103 | 27.8% |
| 82728 | Ferritin (blood protein) level | Office | 2020 | 49 | 71 | $3,955 | $960.44 | 24.3% |
| 81001 | Manual urinalysis test with examination using microscope | Office | 2020 | 177 | 210 | $5,242 | $658.72 | 12.6% |
| 83550 | Iron binding capacity | Office | 2020 | 51 | 73 | $2,608 | $633.26 | 24.3% |
| J1756 | Injection, iron sucrose, 1 mg | Office | 2020 | 14 | 3,400 | $2,754 | $560.11 | 20.3% |
| 83540 | Iron level | Office | 2020 | 51 | 73 | $1,932 | $468.67 | 24.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 28 | 33 | $2,310 | $294.89 | 12.8% |
| 85046 | Red blood count automated, with additional calculations | Office | 2020 | 21 | 37 | $842.49 | $204.66 | 24.3% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2020 | 12 | 12 | $739.44 | $179.16 | 24.2% |
| 86160 | Measurement of complement (immune system proteins) | Office | 2020 | 13 | 14 | $686.70 | $167.52 | 24.4% |
| 85018 | Hemoglobin measurement | Office | 2020 | 25 | 42 | $406.98 | $98.89 | 24.3% |
| 83735 | Magnesium level | Office | 2020 | 13 | 14 | $383.04 | $93.02 | 24.3% |
About Dr. Christopher Poole, MD
Dr. Christopher Poole, MD is a Nephrology healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1558368837.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Poole, MD has received a total of $1,221 in payments from pharmaceutical and medical device companies, with $225.13 received in 2024. These payments were reported across 73 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,100).
As a Medicare-enrolled provider, Poole has provided services to 22,117 Medicare beneficiaries, totaling 40,184 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 149 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Chattanooga, TN
- Active Since 07/01/2005
- Last Updated 05/28/2010
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1558368837
Products in Payments
- LUPKYNIS (Drug) $155.38
- LOKELMA (Drug) $137.28
- SAMSCA (Drug) $98.88
- FARXIGA (Drug) $96.27
- JYNARQUE (Drug) $86.86
- Parsabiv (Drug) $85.53
- Veltassa (Drug) $74.01
- Rituxan (Biological) $71.24
- ACTHAR (Biological) $70.24
- Parsabiv (Biological) $39.73
- INJECTAFER (Drug) $31.34
- NATPARA (Drug) $29.67
- TARPEYO (Drug) $28.41
- FABRAZYME (Biological) $27.22
- Vafseo (Drug) $24.61
- Ozempic (Drug) $18.15
- BENLYSTA (Biological) $16.80
- BRILINTA (Drug) $16.54
- GATTEX (Drug) $15.76
- RAYALDEE (Drug) $15.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Chattanooga
Rohit Gupta, M.d, M.D
Nephrology — Payments: $10,529
Nephrology $10,529
Hans Yehnert, Md, MD
Nephrology — Payments: $5,326
Nephrology $5,326
Nilesh Patel, M.d, M.D
Nephrology — Payments: $3,184
Nephrology $3,184
John Mccarley, M.d, M.D
Nephrology — Payments: $2,939
Nephrology $2,939
Brant Holt, Md, MD
Nephrology — Payments: $2,929
Nephrology $2,929
Mandeep Grewal, Md, MD
Nephrology — Payments: $2,449
Nephrology $2,449